Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP
Clinical trial NCT00565370 · COMPLETED
Trial details
- NCT number
- NCT00565370
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.